Skip to content

A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.

A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application. - A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036428
Enrollment
20
Registered
2019-04-10
Start date
2019-04-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (healthy adults)

Interventions

Applying test products (applying test product A [right face] vs applying test product B [left face]). Applying test products (applying test product B [right face] vs applying test product A [left face

Sponsors

Derma Labo, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: [1]Japanese female aged 35-55 years. [2]Individuals whose wrinkle grade is 3.0 -5.0*. [3]Individuals whose do not apply cosmetics and cuasi-drugs for anti-wrinkle. [4]Individuals who apply 1-3 products for skin care after washing. [5]Individuals who can stop drinking alcohol during the test period. [6]Individuals whose written informed consent has been obtained. *Task Force Committee for Evaluation of Anti-aging Function. Guideline for Evaluation of Anti-wrinkle Products. Journal of Japanese Cosmetic Science Society, 30(4): 316-332, 2006.

Exclusion criteria

Exclusion criteria: [1]Individuals with chronic skin disease, such as atopic dermatitis. [2]Individuals with strange skin conditions at measurement points. [3]Individuals who had been conducted an operation on the test spot. [4]Individuals who is a patient of hay fever and take a drug. [5]Individuals who were took a special facial treatment in the past 1 month. [6]Individuals who have a habit to ingest supplements claiming for brightening effect. [7]Individuals who cannot avoid daylight exposure during the test period. [8]Individuals who had ingested health-promoting foods, foods for specified health uses, health foods, or supplements being effective for the study. [9]Individuals who have a history of serious heart disease, kidney damage, and endocrine disease. [10]Individuals who conduct or have conducted hormone replacement therapy for menopausal disorder. [11]Individuals who take tabaco or alcohol regularly or whose eating habit is irregularity. [12]Subjects who are pregnant or breast-feeding. [13]Individuals judged inappropriate for the trial by the principal.

Design outcomes

Primary

MeasureTime frame
[1]Indexes for evaluating skin condition (doctor's questions and assessment of skin condition(1), photo evaluation(1), skin quality evaluation(1), wrinkle topography(2)). (1)Screening, Week 0, Week 4, Week 8, Week 12. (2)Week 0, Week 4, Week 8, Week 12.

Secondary

MeasureTime frame
[1]Questionnaires about skin condition (Week 0, Week 4, Week 8, Week 12). [2]Subject's diary (From the first day of ingestion of a test material to the last day of the test).

Countries

Japan

Contacts

Public ContactRyoma Shimizu

TES Holdings Co., Ltd. Administrative Department of Clinical Trials

r.shimizu@tes-h.co.jp+81-3-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026